News

The Minister of Health and Solidarity, Madame Agnès Buzyn, appointed Professor Jean-Charles Soria as General Director of Gustave Roussy

The Highly Cited Researchers 2019 List, published by Web of Science Group (Clarivate Analytics), identifies the most influential researchers as determined by their peers all around the world.

Gustave Roussy, leading European Cancer Centre, is collaborating with 16 international partners in the Oncobiome consortium. The objective of the programme is to determine the relationship between intestinal microbial signatures (GOMS) and the incidence, prognosis and resistance to treatment (and toxicity of this) in cancers of breast, colon, lung...

Immunotherapy boosts the immune system to fight cancer cells. Gustave Roussy is a pionner in immunotherapy and the largest tratment facility in Europe. Between 2013 and 2018, 241 immunotherapy-based clinical trials were implemented at the Insitute and 3,317 patients have been treated with immunotherapy. 

By their participation in the initial...

As every year for almost 55 years, the world’s leading cancer experts will meet in Chicago to talk about the latest advances in clinical oncology at the international meeting of the American Society of Clinical Oncology (ASCO).

Gustave Roussy's researchers found an unkown ability to PARP inihibitors - a precision cancer drug used against breast and ovarian cancer - to stimulate the immune system. This study suggests to developp new combinaisons of treatments with immunotherapy.

The Gustave Roussy teams offer you their best wishes for 2019!

Prof. Alexander Eggermont, general director of Gustave Roussy, received the "Docteur Honoris Causa" by The Medical Faculty of the University of Duisburg-Essen for his outstanding achievements.

The Highly Cited Researchers 2018 List, published by Clarivate Analytics on november 27th 2018, identifies the most influential researchers as determined by their peers around the globe.

This year, the European Society for Medical Oncology (ESMO) will take place in Munich, Germany, from 19 to 23 October. It is Europe’s biggest cancer congress and the number of delegates increases year-on-year. Experts from all over the world visit the congress to share the latest clinical innovations in oncology. Around 20,000 delegates from 130...